Viking data suggest obesity drug could rival Zepbound, Wegovy
BioPharma Drive: Drug Pricing
FEBRUARY 27, 2024
The biotech’s drug led to significant weight loss in a Phase 2 trial, causing shares to double as analysts compared results to the marks set by drugs from Eli Lilly and Novo Nordisk.
Let's personalize your content